Ophthalmic Drugs Market By Therapeutic Class (Anti-inflammatory Drugs, Anti-infective Drugs, Anti-glaucoma Drugs, Anti-allergy Drugs, Anti-VEGF Drugs), By Product (Prescription Drugs, OTC Drugs), By Disease Indication, By Distribution Channel & By Region – Global Market Insights 2023 to 2033
Report Highlights
Ophthalmic Drugs Market - Scope of Report
A recent study by Fact.MR on the ophthalmic drugs market offers a 10-year forecast for 2023 to 2033. The study analyzes crucial trends that are currently determining the growth of the market. This report explicates on vital dynamics, such as the drivers, restraints, and opportunities for key market players along with key stakeholders as well as emerging players associated with offering ophthalmic drugs.
The study also provides the dynamics responsible for influencing the future status of the ophthalmic drugs market over the forecast period. A detailed assessment of value chain analysis, business execution, and supply chain analysis across regional markets has been covered in the report.
A list of prominent companies operating in the ophthalmic drugs market, along with their product portfolios, key strategies and SWOT analysis, enhances the reliability of this comprehensive research study.
Report Summary
The study offers comprehensive analysis on diverse features, including production capacities, demand, product developments, revenue generation, and sales of ophthalmic drugs across the globe.
A comprehensive estimate on the market has been provided through an optimistic as well as a conservative scenario, taking into account the sales of ophthalmic drugs during the forecast period. Price point comparison by region with global average price is also considered in the study.
Analysis on Market Size Evaluation
The market has been analyzed for each segment in terms of value (US$ Mn).
Estimates at global and regional levels for ophthalmic drugs are available in terms of “US$ Mn” for value. A Y-o-Y growth contrast on prominent market segments, along with market attractiveness evaluation, has been incorporated in the report. Furthermore, absolute dollar opportunity analysis of all the segments adds prominence to the report.
Absolute dollar opportunity plays a crucial role in assessing the level of opportunity that a manufacturer/distributor can look to achieve, along with identifying potential resources, considering the sales and distribution perspective in the global ophthalmic drugs market.
Inspected Assessment on Regional Segments
Key sections have been elaborated in the report, which have helped deliver projections on regional markets. These chapters include regional macros (political, economic, and business environment outlook), which are expected to have a momentous influence on the growth of the ophthalmic drugs market during the forecast period.
Country-specific valuation on demand for ophthalmic drugs has been offered for each region, along with market scope estimates and forecasts, price index, and impact analysis of the dynamics of prominence in regions and countries. For all regional markets, Y-o-Y growth estimates have also been incorporated in the report.
Detailed breakup in terms of value & volume for emerging countries has also been included in the report.
In-depth Analysis on Competition
The report sheds light on leading manufacturers of ophthalmic drugs, along with their detailed profiles. Essential and up-to-date data related to market performers who are principally engaged in offering ophthalmic drugs has been brought with the help of a detailed dashboard view. Market share analysis and comparison of prominent players provided in the report permits report readers to take preemptive steps in advancing their businesses.
Company profiles have been included in the report, which include essentials such as product portfolios and key strategies, along with all-inclusive SWOT analysis on each player. Company presence is mapped and presented through a matrix for all the prominent players, thus providing readers with actionable insights, which helps in thoughtfully presenting the market status, and predicting the competition level in the ophthalmic drugs domain.
- Table 1 : Product Offering - Major Market Players
- Table 2 : Global Market Size (US$ Mn) Forecast, by Disease Indication, 2023–2033
- Table 3 : Global Market Size (US$ Mn) Forecast, Market Forecast, by Disease Indication – Retinal Disorder, 2023–2033
- Table 4 : Global Market Size (US$ Mn) Forecast, by Therapeutic Class, 2023–2033
- Table 5 : Global Market Size (US$ Mn) Forecast, by Therapeutic Class - Anti-inflammatory Drugs, 2023–2033
- Table 6 : Global Market Size (US$ Mn) Forecast, by Therapeutic Class - Anti-infective Drugs, 2023–2033
- Table 7 : Global Market Size (US$ Mn) Forecast, by Therapeutic Class - Anti-glaucoma Drugs, 2023–2033
- Table 8 : Global Market Size (US$ Mn) Forecast, by Product Type, 2023–2033
- Table 9 : Global Market Size (US$ Mn) Forecast, by Distribution Channel, 2023–2033
- Table 10 : Global Market Size (US$ Mn) Forecast, by Region, 2023–2033
- Table 11 : North America Market Size (US$ Mn) Forecast, by Country, 2023–2033
- Table 12 : North America Market Size (US$ Mn) Forecast, by Disease Indication, 2023–2033
- Table 13 : North America Market Size (US$ Mn) Forecast, Market Forecast, by Disease Indication – Retinal Disorder, 2023–2033
- Table 14 : North America Market Size (US$ Mn) Forecast, by Therapeutic Class, 2023–2033
- Table 15 : North America Market Size (US$ Mn) Forecast, by Therapeutic Class - Anti-inflammatory Drugs, 2023–2033
- Table 16 : North America Market Size (US$ Mn) Forecast, by Therapeutic Class - Anti-infective Drugs, 2023–2033
- Table 17 : North America Market Size (US$ Mn) Forecast, by Therapeutic Class - Anti-glaucoma Drugs, 2023–2033
- Table 18 : North America Market Size (US$ Mn) Forecast, by Product Type, 2023–2033
- Table 19 : North America Market Size (US$ Mn) Forecast, by Distribution Channels, 2023–2033
- Table 20 : Europe Market Size (US$ Mn) Forecast, by Country/Sub-Region, 2023–2033
- Table 21 : Europe Market Size (US$ Mn) Forecast, by Disease Indication, 2023–2033
- Table 22 : Europe Market Size (US$ Mn) Forecast, Market Forecast, by Disease Indication – Retinal Disorder, 2023–2033
- Table 23 : Europe Market Size (US$ Mn) Forecast, by Therapeutic Class, 2023–2033
- Table 24 : Europe Market Size (US$ Mn) Forecast, by Therapeutic Class - Anti-inflammatory Drug, 2023–2033
- Table 25 : Europe Market Size (US$ Mn) Forecast, by Therapeutic Class - Anti-infective Drug, 2023–2033
- Table 26 : Europe Market Size (US$ Mn) Forecast, by Therapeutic Class - Anti-glaucoma Drug, 2023–2033
- Table 27 : Europe Market Size (US$ Mn) Forecast, by Product Type, 2023–2033
- Table 28 : Europe Market Size (US$ Mn) Forecast, by Distribution Channel, 2023–2033
- Table 29 : Asia Pacific Market Size (US$ Mn) Forecast, by Country/Sub-region, 2023–2033
- Table 30 : Asia Pacific Market Size (US$ Mn) Forecast, by Disease Indication, 2023–2033
- Table 31 : Asia Pacific Market Size (US$ Mn) Forecast, by Disease Indication – Retinal Disorder, 2023–2033
- Table 32 : Asia Pacific Market Size (US$ Mn) Forecast, by Therapeutic Class, 2023–2033
- Table 33 : Asia Pacific Market Size (US$ Mn) Forecast, by Therapeutic Class – Anti-inflammatory Drugs, 2023–2033
- Table 34 : Asia Pacific Market Size (US$ Mn) Forecast, by Therapeutic Class – Anti-infective Drugs, 2023–2033
- Table 35 : Asia Pacific Market Size (US$ Mn) Forecast, by Therapeutic Class – Anti-glaucoma Drugs, 2023–2033
- Table 36 : Asia Pacific Market Size (US$ Mn) Forecast, by Product Type, 2023–2033
- Table 37 : Asia Pacific Market Size (US$ Mn) Forecast, by Distribution Channel, 2023–2033
- Table 38 : Latin America Market Size (US$ Mn) Forecast, by Country/Sub-region, 2023–2033
- Table 39 : Latin America Market Size (US$ Mn) Forecast, by Disease Indication, 2023–2033
- Table 40 : Latin America Market Size (US$ Mn) Forecast, by Disease Indication – Retinal Disorder, 2023–2033
- Table 41 : Latin America Market Size (US$ Mn) Forecast, by Therapeutic Class, 2023–2033
- Table 42 : Latin America Market Size (US$ Mn) Forecast, by Therapeutic Class – Anti-inflammatory Drugs, 2023–2033
- Table 43 : Latin America Market Size (US$ Mn) Forecast, by Therapeutic Class – Anti-infective Drugs, 2023–2033
- Table 44 : Latin America Market Size (US$ Mn) Forecast, by Therapeutic Class – Anti-glaucoma Drugs, 2023–2033
- Table 45 : Latin America Market Size (US$ Mn) Forecast, by Product Type, 2023–2033
- Table 46 : Latin America Market Size (US$ Mn) Forecast, by Distribution Channel, 2023–2033
- Table 47 : Middle East & Africa Market Size (US$ Mn) Forecast, by Country/Sub-Region, 2023–2033
- Table 48 : Middle East & Africa Market Size (US$ Mn) Forecast, by Disease Indication, 2023–2033
- Table 49 : Middle East & Africa Market Size (US$ Mn) Forecast, by Disease Indication - Retinal Disorder, 2023–2033
- Table 50 : Middle East & Africa Market Size (US$ Mn) Forecast, by Therapeutic Class, 2023–2033
- Table 51 : Middle East & Africa Market Size (US$ Mn) Forecast, by Therapeutic Class - Anti-inflammatory Drugs, 2023–2033
- Table 52 : Middle East & Africa Market Size (US$ Mn) Forecast, by Therapeutic Class - Anti-infective Drugs, 2023–2033
- Table 53 : Middle East & Africa Market Size (US$ Mn) Forecast, by Therapeutic Class - Anti-glaucoma Drugs, 2023–2033
- Table 54 : Middle East & Africa Market Size (US$ Mn) Forecast, by Product Type, 2023–2033
- Table 55 : Middle East & Africa Market Size (US$ Mn) Forecast, by Distribution Channel, 2023–2033
- Figure 1 : Global Market Size (US$ Mn) Forecast, 2023–2033
- Figure 2 : Global Company Share: Anti-glaucoma Drugs, 2018
- Figure 3 : Global Causes of Blindness
- Figure 4 : U.S. - Causes of Blindness
- Figure 5 : Europe - Causes of Blindness
- Figure 6 : Japan Causes of Blindness
- Figure 7 : Global Market Attractiveness, by Disease Indication, 2023–2033
- Figure 8 : Global Market Value Share, by Disease Indication, 2023 and 2033
- Figure 9 : Global Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Dry Eye, 2023–2033
- Figure 10 : Global Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Glaucoma, 2023–2033
- Figure 11 : Global Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Infection/Inflammation, 2023–2033
- Figure 12 : Global Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Retinal Disorders, 2023–2033
- Figure 13 : Global Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Uveitis, 2023–2033
- Figure 14 : Global Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Allergy, 2023–2033
- Figure 15 : Global Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Other Ophthalmic Diseases, 2023–2033
- Figure 16 : Global Market Attractiveness, by Therapeutic Class, 2023–2033
- Figure 17 : Global Market Value Share, by Therapeutic Class, 2023 and 2033
- Figure 18 : Global Market, by Anti-infective Drugs, Revenue (US$ Mn) and Y-o-Y Growth Projection (%), 2023–2033
- Figure 19 : Global Market, by Anti-inflammatory Drugs Revenue (US$ Mn) and Y-o-Y Growth Projection (%), 2023–2033
- Figure 20 : Global Market, by Anti-glaucoma Drugs, Revenue (US$ Mn) and Y-o-Y Growth Projection (%), 2023–2033
- Figure 21 : Global Market, by Anti-VEGF Agents, Revenue (US$ Mn) and Y-o-Y Growth Projection (%), 2023–2033
- Figure 22 : Global Market, by Anti-allergy Drugs, Revenue (US$ Mn) and Y-o-Y Growth Projection (%), 2023–2033
- Figure 23 : Global Market, by Others Drugs, Revenue (US$ Mn) and Y-o-Y Growth Projection (%), 2023–2033
- Figure 24 : Global Market Value Share, by Product Type, for 2023 and 2033
- Figure 25 : Global Market Attractiveness, by Product Type, 2023–2033
- Figure 26 : Global Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Prescription Drugs, 2023–2033
- Figure 27 : Global Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by OTC Drugs, 2023–2033
- Figure 28 : Global Market Value Share, by Distribution Channel, for 2023 and 2033
- Figure 29 : Global Market Attractiveness, by Distribution Channel, 2023–2033
- Figure 30 : Global Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Online Pharmacies, 2023–2033
- Figure 31 : Global Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Hospital Pharmacies, 2023–2033
- Figure 32 : Global Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Independent Pharmacies & Drug Stores, 2023–2033
- Figure 33 : Global Market Value Share, by Region, for 2023 and 2033
- Figure 34 : Global Market Attractiveness, by Region, 2023–2033
- Figure 35 : North America Market Size (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2023–2033
- Figure 36 : North America Market Attractiveness, by Country, 2023–2033
- Figure 37 : North America Market Value Share, by Country, 2023 and 2033
- Figure 38 : North America Market Attractiveness, By Disease Indication, 2023–2033
- Figure 39 : North America Market Value Share, by Disease Indication, 2023 and 2033
- Figure 40 : North America Market Value Share, by Therapeutic Class, 2023 and 2033
- Figure 41 : North America Market Attractiveness, by Therapeutic Class, 2023–2033
- Figure 42 : North America Market Value Share Analysis, by Product Type, 2023 and 2033
- Figure 43 : North America Market Attractiveness, by Product Type, 2023–2033
- Figure 44 : North America Market Value Share, by Distribution Channels, 2023 and 2033
- Figure 45 : North America Market Attractiveness, by Distribution Channels, 2023–2033
- Figure 46 : Europe Market Size (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2023–2033
- Figure 47 : Europe Market Attractiveness, by Country/Sub-Region, 2023–2033
- Figure 48 : Europe Market Value Share, by Country/Sub-Region, 2023 and 2033
- Figure 49 : Europe Market Attractiveness, By Disease Indication, 2015-2025
- Figure 50 : Europe Market Value Share, by Disease Indication, 2023 and 2033
- Figure 51 : Europe Market Value Share, by Therapeutic Class, 2023 and 2033
- Figure 52 : Europe Market Attractiveness, by Therapeutic Class, 2023–2033
- Figure 53 : Europe Market Value Share Analysis, by Product Type, 2023 and 2033
- Figure 54 : Europe Market Attractiveness, by Product Type, 2023–2033
- Figure 55 : Europe Market Value Share, by Distribution Channel, 2023 and 2033
- Figure 56 : Europe Market Attractiveness, by Distribution Channel, 2023–2033
- Figure 57 : Asia Pacific Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2023–2033
- Figure 58 : Asia Pacific Market Attractiveness, by Country/Sub-region, 2023–2033
- Figure 59 : Asia Pacific Market Value Share, by Country/Sub-region, for 2023 and 2033
- Figure 60 : Asia Pacific Market Attractiveness, by Disease Indication, 2023–2033
- Figure 61 : Asia Pacific Market Value Share, by Disease Indication, for 2023 and 2033
- Figure 62 : Asia Pacific Market Attractiveness, by Therapeutic Class, 2023–2033
- Figure 63 : Asia Pacific Market Value Share, by Therapeutic Class, for 2023 and 2033
- Figure 64 : Asia Pacific Market Value Share Analysis, by Product Type, for 2023 and 2033
- Figure 65 : Asia Pacific Market Attractiveness, by Product Type, 2023–2033
- Figure 66 : Asia Pacific Market Value Share, by Distribution Channel, for 2023 and 2033
- Figure 67 : Asia Pacific Market Attractiveness, by Distribution Channel, 2023–2033
- Figure 68 : Latin America Market Size (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2023–2033
- Figure 69 : Latin America Market Attractiveness, by Country/Sub-region, 2023–2033
- Figure 70 : Latin America Market Value Share, by Country/Sub-region, 2023 and 2033
- Figure 71 : Latin America Market Attractiveness, by Disease Indication, 2023–2033
- Figure 72 : Latin America Market Value Share, by Disease Indication, 2023 and 2033
- Figure 73 : Latin America Market Attractiveness, by Therapeutic Class, 2023–2033
- Figure 74 : Latin America Market Value Share, by Therapeutic Class, 2023 and 2033
- Figure 75 : Latin America Market Value Share Analysis, by Product Type, 2023 and 2033
- Figure 76 : Latin America Market Attractiveness, by Product Type, 2023–2033
- Figure 77 : Latin America Market Value Share, by Distribution Channel, 2023 and 2033
- Figure 78 : Latin America Market Attractiveness, by Distribution Channel, 2023–2033
- Figure 79 : Middle East & Africa Market Size (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2023–2033
- Figure 80 : Middle East & Africa Market Attractiveness, by Country/Sub-Region, 2023–2033
- Figure 81 : Middle East & Africa Market Value Share, by Country/Sub-Region, 2023 and 2033
- Figure 82 : Middle East & Africa Market Attractiveness, by Disease Indication, 2023–2033
- Figure 83 : Middle East & Africa Market Value Share, by Disease Indication, 2023 and 2033
- Figure 84 : Middle East & Africa Market Attractiveness, by Therapeutic Class, 2023–2033
- Figure 85 : Middle East & Africa Market Value Share, by Therapeutic Class, 2023 and 2033
- Figure 86 : Middle East & Africa Market Value Share Analysis, by Product Type, 2023 and 2033
- Figure 87 : Middle East & Africa Market Attractiveness, by Product Type, 2023–2033
- Figure 88 : Middle East & Africa Market Value Share, by Distribution Channel, 2023 and 2033
- Figure 89 : Middle East & Africa Market Attractiveness, by Distribution Channel, 2023–2033
- Figure 90 : Global Market Share, by Company, 2018
Fact.MR is an independent, pure play market intelligence firm incorporated with an objective to deliver high quality, customized market research solutions that help our clients successfully go to the market equipped with actionable insights capable of impacting crucial business decisions.
Similar Reports from Fact Market Research
Opthalmic Drugs Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2020 to 2025
Global Ophthalmic Drugs Market- Scope of the Report
The recent study by Fact.MR on global ophthalmic drugs market offers a 5-year forecast between 2020 and 2025. The study analyzes crucial trends that are currently determining the growth of the global ophthalmic drugs market. This report explicates on vital dynamics such as the drivers, restraints and opportunities for key market players ...